London Cancer is one of the most active clinical research networks in the country, with one in seven of all chief investigators for the National Institute for Health Research (NIHR) portfolio studies based in one of our partner trusts. In 2015/16, 3,697 patients took part in 234 studies across London Cancer.
London Cancer has the benefit of two Experimental Cancer Medicine Centres supported by the Department of Health and Cancer Research UK, giving patients access to the most novel and exciting new therapies before they are adopted by the wider NHS.
London Cancer is committed to supporting research into cancer prevention and is bringing together experts in public health, psychology, health behaviour and social geography to explore new avenues.
Work to help diagnose cancers earlier is being informed by research into the barriers that patients face in accessing health care when they need it. Researchers in London Cancer are at the forefront of research into issues that affect patient experience and wellbeing after treatment. We are working to stimulate wider involvement in understanding of the issues faced by those living with and beyond cancer.
The NIHR CRN was established in 2014, and covers the London Cancer region. The organisation is hosted by Barts Health NHS Trust and is one of 15 research networks in operation. The CRN is led by clinical divisional leads Dr Adele Fielding and Dr David Chao. In 2015/16, 5,368 patients took part in 254 clinical trials and studies across the whole of UCL Partners geography. Click here to visit the NIHR website and read more about the CRN North Thames.
We are collaborating with leading academic and research organisations on a number of research projects. These include: